Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
Discovery Medicine
|
August 14, 2010
Systemic lupus erythematosus (SLE): Trials and issues
Ioana Moldovan, Ellen M Ginzler
Seminars in Respiratory and Critical Care Medicine
|
September 4, 2007
Pulmonary manifestations of systemic lupus erythematosus
Beatrice Memet, Ellen M Ginzler
Rheumatic Diseases Clinics of North America
|
June 1, 2005
Newer therapeutic approaches for systemic lupus erythematosus
Ellen M Ginzler, Olga Dvorkina
Current Opinion in Rheumatology
|
August 18, 2004
Systemic lupus erythematosus trials: successes and issues
Ellen M Ginzler, Ioana Moldovan
Rheumatic Diseases Clinics of North America
|
March 6, 2010
Endothelial function and its implications for cardiovascular and renal disease in systemic lupus erythematosus
Robert Clancy, Ellen M Ginzler
Rheumatic Diseases Clinics of North America
|
March 1, 2006
Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents
Mary Anne Dooley, Ellen M Ginzler
Transplantation
|
October 28, 2005
Use of mycophenolate mofetil in autoimmune and renal diseases
Gerald B Appel, Jai Radhakrishnan, Ellen M Ginzler
Cureus
|
March 6, 2023
Mycophenolate Mofetil for Systemic Lupus Erythematosus: Our 20-Year Experience
Michael Trevisonno, Alexander Hall, Sabrina Rosengarten, et al.
Reumatologia Clinica
|
July 29, 2011
[Treatment of lupus nephritis]
Lucía Silva Fernández, José Luis Andréu Sánchez, Ellen M Ginzler
Arthritis and Rheumatism
|
December 30, 2009
Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial
Ellen M Ginzler, David Wofsy, David Isenberg, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
Discovery Medicine
|
August 14, 2010
Systemic lupus erythematosus (SLE): Trials and issues
Ioana Moldovan, Ellen M Ginzler
Seminars in Respiratory and Critical Care Medicine
|
September 4, 2007
Pulmonary manifestations of systemic lupus erythematosus
Beatrice Memet, Ellen M Ginzler
Rheumatic Diseases Clinics of North America
|
June 1, 2005
Newer therapeutic approaches for systemic lupus erythematosus
Ellen M Ginzler, Olga Dvorkina
Current Opinion in Rheumatology
|
August 18, 2004
Systemic lupus erythematosus trials: successes and issues
Ellen M Ginzler, Ioana Moldovan
Rheumatic Diseases Clinics of North America
|
March 6, 2010
Endothelial function and its implications for cardiovascular and renal disease in systemic lupus erythematosus
Robert Clancy, Ellen M Ginzler
Rheumatic Diseases Clinics of North America
|
March 1, 2006
Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents
Mary Anne Dooley, Ellen M Ginzler
Transplantation
|
October 28, 2005
Use of mycophenolate mofetil in autoimmune and renal diseases
Gerald B Appel, Jai Radhakrishnan, Ellen M Ginzler
Cureus
|
March 6, 2023
Mycophenolate Mofetil for Systemic Lupus Erythematosus: Our 20-Year Experience
Michael Trevisonno, Alexander Hall, Sabrina Rosengarten, et al.
Reumatologia Clinica
|
July 29, 2011
[Treatment of lupus nephritis]
Lucía Silva Fernández, José Luis Andréu Sánchez, Ellen M Ginzler
Arthritis and Rheumatism
|
December 30, 2009
Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial
Ellen M Ginzler, David Wofsy, David Isenberg, et al.
Page
of 9